Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 66 articles:
HTML format



Single Articles


    September 2021
  1. ESDAILLE AR, Ibilibor C, Ii AH, Palmer NR, et al
    Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
    Urology. 2021 Sep 25. pii: S0090-4295(21)00893.
    PubMed     Abstract available


    August 2021
  2. BREE KK, Hensley PJ, Pettaway CA
    Germline Mutations in African American Men with Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
    Urology. 2021 Aug 25. pii: S0090-4295(21)00796.
    PubMed     Abstract available


  3. POSIELSKI N, Frankel J, Kuo HC, Ho O, et al
    IMPACT OF AGE AND RACE ON HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER.
    Urology. 2021 Aug 21. pii: S0090-4295(21)00783.
    PubMed     Abstract available


  4. VINCE RA JR, Jamieson S, Mahal B, Iii WU, et al
    Examining the Racial Disparities in Prostate Cancer.
    Urology. 2021 Aug 18. pii: S0090-4295(21)00772.
    PubMed     Abstract available


  5. BERG RNWV, Basourakos SP, Shoag J, Scherr D, et al
    Prostate Cancer Screening for Gay Men in the United States.
    Urology. 2021 Aug 8. pii: S0090-4295(21)00734.
    PubMed     Abstract available


  6. JAMIESON SC, Mallory CW, Jivanji DR, Perez A, et al
    THE ROLE OF HEALTH LITERACY IN PROSTATE CANCER SCREENING.
    Urology. 2021 Aug 7. pii: S0090-4295(21)00735.
    PubMed     Abstract available


  7. LEWICKI P, Arenas-Gallo C, Basourakos SP, Awamlh BAHA, et al
    Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2.
    Urology. 2021 Aug 3. pii: S0090-4295(21)00722.
    PubMed    


    July 2021
  8. DEROUEN MC, Yang J, Jain J, Weden MM, et al
    Disparities in prostate cancer survival according to neighborhood archetypes, a population-based study.
    Urology. 2021 Jul 22. pii: S0090-4295(21)00674.
    PubMed     Abstract available


  9. PATEL HD, Doshi CP, Koehne EL, Hart S, et al
    African American Men have Increased Risk of Prostate Cancer Detection despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.
    Urology. 2021 Jul 21. pii: S0090-4295(21)00678.
    PubMed     Abstract available


  10. SESSINE MS, Das S, Park B, Salami SS, et al
    Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
    PubMed     Abstract available


    June 2021
  11. PIERRE-VICTOR D, Parnes HL, Andriole GL, Pinsky PF, et al
    Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00539.
    PubMed     Abstract available


  12. CHANDRASEKAR T, Bowler N, Schneider A, Goldberg H, et al
    Outcomes of Active Surveillance for Men with Intermediate Risk Prostate Cancer, A Population-Based Analysis.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00560.
    PubMed     Abstract available


  13. KAWA SM, Stroomberg HV, Larsen SB, Helgstrand JT, et al
    Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period.
    Urology. 2021 Jun 22. pii: S0090-4295(21)00538.
    PubMed     Abstract available


  14. CAMPBELL RA, Li J, Malone L, Levy DA, et al
    Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
    Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
    PubMed     Abstract available


  15. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
    Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
    Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
    PubMed     Abstract available


  16. CHAO B, Lepor H
    5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.
    Urology. 2021 Jun 3. pii: S0090-4295(21)00460.
    PubMed     Abstract available


    May 2021
  17. HESTERBERG AB, Gordetsky JB, Hurley PJ
    Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.
    Urology. 2021 May 28. pii: S0090-4295(21)00442.
    PubMed     Abstract available


  18. KING MC, Sardi A, Velez-Mejia C, Sittig M, et al
    Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Urology. 2021 May 25. pii: S0090-4295(21)00435.
    PubMed     Abstract available


  19. ARMSTRONG N, Bahl A, Pinkawa M, Ryder S, et al
    SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review.
    Urology. 2021 May 22. pii: S0090-4295(21)00421.
    PubMed     Abstract available


  20. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
    Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
    Urology. 2021 May 7. pii: S0090-4295(21)00368.
    PubMed     Abstract available


  21. KF R
    Re: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 May 1. pii: S0090-4295(21)00355.
    PubMed    


    April 2021
  22. PAUDEL R, Ferrante S, Qi J, Dunn RL, et al
    Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative.
    Urology. 2021 Apr 29. pii: S0090-4295(21)00350.
    PubMed     Abstract available


  23. NORRIS JM, Ball R, Freeman A, Ghei M, et al
    Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
    Urology. 2021 Apr 3. pii: S0090-4295(21)00301.
    PubMed    


    February 2021
  24. MARCHETTI KA, Oerline M, Hollenbeck BK, Kaufman SR, et al
    Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
    Urology. 2021 Feb 18. pii: S0090-4295(21)00182.
    PubMed     Abstract available


  25. WOON DTS, Finelli A, Cheung DC, Martin LJ, et al
    A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide.
    Urology. 2021 Feb 13. pii: S0090-4295(21)00172.
    PubMed     Abstract available


  26. POSIELSKI NM, Richards KA, Liou JI, Borza T, et al
    Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients with Advanced Prostate Cancer: A Veterans Administration Cohort Study.
    Urology. 2021 Feb 12. pii: S0090-4295(21)00173.
    PubMed     Abstract available


  27. HEMAL S, DeWitt-Foy M, Klein EA
    Management of a Prostate Cancer Patient with inherited germline BRCA1 and BRCA2 mutations, a Case Report.
    Urology. 2021 Feb 5. pii: S0090-4295(21)00120.
    PubMed     Abstract available


  28. VOELZKE BB, Leddy LS, Myers JB, Breyer BN, et al
    Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 Feb 5. pii: S0090-4295(21)00121.
    PubMed     Abstract available


  29. JIBARA G, Sjoberg DD, Stearns GL, Stabholz Y, et al
    Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.
    Urology. 2021 Feb 1. pii: S0090-4295(21)00112.
    PubMed     Abstract available


    January 2021
  30. MICHAEL J, Khandani AH, Basak R, Tan HJ, et al
    Patterns of recurrence, detection rates, and impact of 18-F Fluciclovine PET/CT on the management of men with recurrent prostate cancer.
    Urology. 2021 Jan 29. pii: S0090-4295(21)00110.
    PubMed     Abstract available


  31. HUYNH LM, Keit E, Huang E, Et Al, et al
    Protective Effects of Metformin against Biochemical Failure Following Radical Prostatectomy or Radiation Therapy in Localized Prostate Cancer.
    Urology. 2021 Jan 27. pii: S0090-4295(21)00092.
    PubMed     Abstract available


  32. XU J, Bock C, Janisse J, Schwartz KL, et al
    Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
    Urology. 2021 Jan 19. pii: S0090-4295(21)00064.
    PubMed     Abstract available


    December 2020
  33. HOFMANN MR, Hussain M, Dehm SM, Beltran H, et al
    Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31519.
    PubMed     Abstract available


  34. HANDLEY NR, Feng FY, Guise TA, D'Andrea D, et al
    Preserving Well-being in Patients With Advanced and Late Prostate Cancer.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31513.
    PubMed     Abstract available


  35. MCMAHON S, Basak R, Zhou X, Smith AB, et al
    Patient-Reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment.
    Urology. 2020 Dec 19. pii: S0090-4295(20)31498.
    PubMed     Abstract available


  36. ALANEE S, Peabody J, Menon M
    Prostate Cancer Undetected by mpMRI: Tumour Conspicuity is Reliant Upon Optimal Scan Timing and Quality.
    Urology. 2020 Dec 3. pii: S0090-4295(20)31428.
    PubMed    


  37. NORRIS JM, Allen C, Ball R, Freeman A, et al
    Prostate Cancer Undetected by mpMRI: Tumour Conspicuity is Reliant Upon Optimal Scan Timing and Quality.
    Urology. 2020 Dec 2. pii: S0090-4295(20)31427.
    PubMed    


    November 2020
  38. SCHMANKE K, Okut H, Ablah E
    Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016).
    Urology. 2020 Nov 20. pii: S0090-4295(20)31399.
    PubMed     Abstract available


  39. BHATTU AS, Zappala SM, Parekh DJ, Punnen S, et al
    A 4Kscore cut-off of 7.5% for prostate biopsy decisions provides high sensitivity and negative predictive value for significant prostate cancer.
    Urology. 2020 Nov 17. pii: S0090-4295(20)31371.
    PubMed     Abstract available


  40. GREENBERG JW, Leinwand G, Feibus AH, Haney NM, et al
    Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer.
    Urology. 2020 Nov 6. pii: S0090-4295(20)31346.
    PubMed     Abstract available


    October 2020
  41. SOETERIK TFW, van Melick HHE, Dijksman LM, Biesma DH, et al
    Multi-parametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification.
    Urology. 2020 Oct 28. pii: S0090-4295(20)31296.
    PubMed     Abstract available


  42. DE ALMEIDA RVS, Silvino JRC, Kalil JR, Junior VLDS, et al
    Early Effects of High-Intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology.
    Urology. 2020 Oct 17. pii: S0090-4295(20)31265.
    PubMed     Abstract available


    September 2020
  43. WINOKER JS, Wajswol E, Falagario U, Maritini A, et al
    Transperineal versus transrectal targeted biopsy with use of electromagnetically-tracked MR/US fusion guidance platform for the detection of clinically significant prostate cancer.
    Urology. 2020 Sep 18. pii: S0090-4295(20)31137.
    PubMed     Abstract available


  44. GINSBURG KB, Jacobs JC, Qi J, Kaye DR, et al
    Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance.
    Urology. 2020 Sep 15. pii: S0090-4295(20)31125.
    PubMed     Abstract available


  45. ALANEE S, Deebajah M, Taneja K, Cole D, et al
    Post prostatectomy Pathologic Findings of Patients with Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging.
    Urology. 2020 Sep 15. pii: S0090-4295(20)31127.
    PubMed     Abstract available


  46. SHIRK JD
    RE: 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
    Urology. 2020 Sep 9. pii: S0090-4295(20)31012.
    PubMed    


    August 2020
  47. KARSIYAKALI N, Ozgen MB, Ozveren B, Akbal C, et al
    Sub-optimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy.
    Urology. 2020 Aug 29. pii: S0090-4295(20)31028.
    PubMed     Abstract available


  48. THOMAS L, Sharifi N
    Germline HSD3B1 Genetics and Prostate Cancer Outcomes.
    Urology. 2020 Aug 28. pii: S0090-4295(20)31025.
    PubMed     Abstract available


  49. WAKE N, Bjurlin MA
    Author Reply: 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
    Urology. 2020 Aug 28. pii: S0090-4295(20)31010.
    PubMed    


  50. LAMBA N, Butler S, Mahal BA, Trinh QD, et al
    Three-tiered sub-classification system of high-risk prostate cancer in men managed with radical prostatectomy: Implications for treatment decision-making.
    Urology. 2020 Aug 4. pii: S0090-4295(20)30949.
    PubMed     Abstract available


  51. KAHOKEHR AA, Boysen WR, Schild MH, Nose BD, et al
    Urinary pubic symphysis fistula leads to histopathologic osteomyelitis in prostate cancer survivors.
    Urology. 2020 Aug 4. pii: S0090-4295(20)30947.
    PubMed     Abstract available


    July 2020
  52. WU Y, Wang Y, Gu Y, Xia J, et al
    Prostate Cancer Risk and Prognostic Influence Among Users of 5-Alpha-Reductase Inhibitors and Alpha-Blockers: A Systematic Review and Meta-Analysis.
    Urology. 2020 Jul 31. pii: S0090-4295(20)30932.
    PubMed     Abstract available


  53. CIPRUT SE, Kelly MD, Walter D, Hoffman R, et al
    A Clinical Reminder Order Check (CROC) Intervention to Improve Guideline-Concordant Imaging Practices for men with Prostate Cancer: A Pilot Study.
    Urology. 2020 Jul 25. pii: S0090-4295(20)30888.
    PubMed     Abstract available


  54. BARQAWI A, Pessoa RR, Al-Musawi M, MacDermott T, et al
    THE IMPACT OF PERFORMING A 3D MAPPING BIOPSY PRIOR TO PRIMARY CRYOTHERAPY FOR THE TREATMENT OF PROSTATE CANCER.
    Urology. 2020 Jul 22. pii: S0090-4295(20)30867.
    PubMed     Abstract available


  55. MATSUGASUMI T, Shiraishi T, Fujihara A, Ohashi M, et al
    Targeted focal cryoablation for prostate cancer with real-time Transrectal Ultrasound guided free-hands technique: A step-by-step technique.
    Urology. 2020 Jul 16. pii: S0090-4295(20)30847.
    PubMed     Abstract available


  56. O'CONNOR LP, Wang AZ, Yerram NK, Lebastchi AH, et al
    Combined MRI-targeted plus systematic confirmatory biopsy improves risk stratification for patients enrolling on active surveillance for prostate cancer.
    Urology. 2020 Jul 14. pii: S0090-4295(20)30828.
    PubMed     Abstract available


  57. YAN H, Dittmar F, Schagdarsurengin U, Wagenlehner F, et al
    The clinical application and potential roles of circulating tumor cells in bladder cancer and prostate cancer.
    Urology. 2020 Jul 4. pii: S0090-4295(20)30799.
    PubMed     Abstract available


    June 2020
  58. WAKE N, Nussbaum JE, Elias MI, Nikas CV, et al
    3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
    Urology. 2020 Jun 11. pii: S0090-4295(20)30663.
    PubMed     Abstract available


  59. CULLEN J, Kuo HC, Shan J, Lu R, et al
    The 17-Gene Genomic Prostate Score Test as a Predictor of Outcomes in Men with Unfavorable Intermediate Risk Prostate Cancer.
    Urology. 2020 Jun 7. pii: S0090-4295(20)30623.
    PubMed     Abstract available


  60. KAUFMAN ME, Miller DT, Ullah A, White J, et al
    Skene's Gland Adenocarcinoma: Borrowing from Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy.
    Urology. 2020 Jun 3. pii: S0090-4295(20)30632.
    PubMed     Abstract available


    May 2020
  61. IINUMA K, Nakano M, Kato T, Kato D, et al
    Assessment of long-term changes in lower urinary tract symptoms in patients with prostate cancer who underwent low-dose-rate prostate brachytherapy.
    Urology. 2020 May 13. pii: S0090-4295(20)30540.
    PubMed     Abstract available


  62. NOSE BD, Boysen WR, Kahokehr AA, Inouye BM, et al
    Extirpative cultures reveal infectious pubic bone osteomyelitis in prostate cancer survivors with urinary-pubic symphysis fistulae (UPF).
    Urology. 2020 May 7. pii: S0090-4295(20)30520.
    PubMed     Abstract available


    April 2020
  63. FROEHNER M, Koch R, Hubler M, Lindner M, et al
    Quantifying the relationship between increasing life expectancy and non-prostate cancer mortality after radical prostatectomy.
    Urology. 2020 Apr 22. pii: S0090-4295(20)30435.
    PubMed     Abstract available


  64. PARTIN AW
    Commentary RE: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium & Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Glea
    Urology. 2020 Apr 17. pii: S0090-4295(20)30422.
    PubMed    


  65. BARRY M, Fowler J
    Commentary RE: Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.
    Urology. 2020 Apr 16. pii: S0090-4295(20)30401.
    PubMed    


  66. WYSOCK JS, Becher E, Persily J, Loeb S, et al
    Concordance and Performance of 4Kscore(R) and SelectMDx(R) for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.
    Urology. 2020 Apr 12. pii: S0090-4295(20)30339.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: